CONCIZUMAB
UNII 68603V9EAF

Substance Identification & Data

This profile provides standardized clinical and technical data for Concizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 68603V9EAF.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1312299-39-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

68603V9EAF

CAS Registry Number

1312299-39-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CONCIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

68603V9EAF

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C166914

National Cancer Institute reference terminology for clinical and research data.

INN ID

9636

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-127

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Concizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CONCIZUMAB

CONCIZUMAB-MTCI

Common Names & Synonyms

CONCIZUMAB [INN]

CONCIZUMAB [JAN]

CONCIZUMAB [USAN]

CONCIZUMAB [WHO-DD]

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS TFPI (TISSUE FACTOR PATHWAY INHIBITOR, LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR)), HUMANIZED MONOCLONAL ANTIBODY

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS TISSUE FACTOR PATHWAY INHIBITOR (LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR, TFPI))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.4 HEAVY CHAIN (1-448) (HUMANIZED VH (HOMO SAPIENS IGHV3-21*01 (86%) (IGHD)-IGHJ6*01 (93%)) (8.8.14) (1-121)-HOMO SAPIENS IGHG4*01 (HINGE(S10>P(229))) (122-448)) (135-219')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-219') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV2-29*02 (90%) IGKJ4*01)(11.3.9) (1'-112')-HOMO SAPIENS IGKC*01 (113'-219')), DIMER (227-227'':230-230'')-BISDISULFIDE